Veterinary Medicines

Bovilis Ringvac <9 and >21 Lyophilisate+solvent for suspension for injection

Authorised
  • Trichophyton verrucosum, strain LTF-130, Live
Download as PDF

Product identification

Medicine name:
Bovilis Ringvac <9 and >21 Lyophilisate+solvent for suspension for injection
Bovilis Ringvac Lyofilisaat en oplosmiddel voor suspensie voor injectie
Bovilis Ringvac Lyophilisat et solvant pour suspension injectable
Bovilis Ringvac Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
  • Trichophyton verrucosum, strain LTF-130, Live
Target species:
  • Cattle
  • Cattle (calf)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton verrucosum, strain LTF-130, Live
    21000000.00
    cells
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AP01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • (ID2) 40 millilitre(s); 40 Dose: Box (Cardboard) with 1 Bottle (Glass) with 40 Dose and 1 Bottle (Glass) with 40 millilitre(s)
  • (ID1) 10 Dose; 10 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V506124
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0231/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • France
  • Greece
  • Hungary
  • Ireland
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."